September 20, 2010: Cardiovascular and Renal Drugs Advisory Committee Meeting ... - Bioscience Technology PDF Print
Bioscience TechnologyBy Federal Drug Administration Friday, August 27, 2010 The committee will discuss new drug application (NDA) 22–512, dabigatran etexilate mesylate capsules,

... read more

 
Share |
Copyright © 2026 Global Dialysis. All Rights Reserved.